Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Q2 Results
View:
Post by QContinuum1 on Aug 14, 2024 7:16am

Q2 Results

Meh.  Issue isn't that they're meh, issue is that they can't grow top line (especially in Germany) when others are doing so.  This business isn't going anywhere.  Let the selloff commence.
Comment by Macpoor on Aug 14, 2024 7:23am
Rom was not a day! Building a business takes time. Think about Amazon, 3o years ago was a tiny company but today is a different ballgame. So LABS has products and there are demands for it. 
Comment by QContinuum1 on Aug 14, 2024 7:47am
LABS is becoming an ever-decreasing small voice in an ever-increasing large choir. Other are growing at double digits and are actually penetrating in the global markets that LABS apparently has 'strong partnerships' in.  If LABS can't grow in those jurisdictions, with the partners they have, the competition won't stop growing and there is only so much share to go around. The ...more  
Comment by Macpoor on Aug 14, 2024 8:12am
I am waiting what the management team will say in an hour.  I hope that they give us a clear message for upcoming months ahead. You never know . The world of stock market is full of surprises and ambiguities! At the end , I just wish to have power to move those stock to at least over 30 cents:)) Good luck!
Comment by QContinuum1 on Aug 14, 2024 8:30am
Management call will be a waste of time.  They will do nothing more than say they are pleased with the progress and trend and that things are headed in the right direction.  They will not go off script from what the NR states, and, I expect, will just simply point to 'ongoing initiatives' for future positivity without speaking to what those things are. No matter how you look at ...more  
Comment by CADInvestor12 on Aug 14, 2024 8:36am
Inbetween meh & good, unfortunately no catalysts in PR/ MD&A that we were hoping for. Issue with top line is from Canadian market .. for whatever reason, they cannot profitably grow their domestic portfolio. Germany grew 70% QoQ & Australia 16% ..  WTF is going on in Brazil
Comment by QContinuum1 on Aug 14, 2024 8:47am
But they only grew in Germany because of Drobaninol.  That is not good enough.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities